These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 22371890)
1. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Martinez MN; Papich MG; Drusano GL Antimicrob Agents Chemother; 2012 Jun; 56(6):2795-805. PubMed ID: 22371890 [TBL] [Abstract][Full Text] [Related]
2. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury. Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and pharmacodynamic parameters of antimicrobials: potential for providing dosing regimens that are less vulnerable to resistance. Adembri C; Novelli A Clin Pharmacokinet; 2009; 48(8):517-28. PubMed ID: 19705922 [TBL] [Abstract][Full Text] [Related]
5. The contribution of pharmacokinetic-pharmacodynamic modelling with Monte Carlo simulation to the development of susceptibility breakpoints for Neisseria meningitidis. Burgess DS; Frei CR; Lewis Ii JS; Fiebelkorn KR; Jorgensen JH Clin Microbiol Infect; 2007 Jan; 13(1):33-9. PubMed ID: 17184285 [TBL] [Abstract][Full Text] [Related]
6. Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. Gonzalez D; Schmidt S; Derendorf H Clin Microbiol Rev; 2013 Apr; 26(2):274-88. PubMed ID: 23554417 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of antimicrobials. Roberts JA; Norris R; Paterson DL; Martin JH Br J Clin Pharmacol; 2012 Jan; 73(1):27-36. PubMed ID: 21831196 [TBL] [Abstract][Full Text] [Related]
12. Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis. Wu J; Wu H; Wang Y; Chen Y; Guo B; Cao G; Wu X; Yu J; Wu J; Zhu D; Guo Y; Yuan H; Hu F; Zhang J Clin Ther; 2019 Jun; 41(6):1164-1174.e4. PubMed ID: 31126694 [TBL] [Abstract][Full Text] [Related]
13. The integration of pharmacokinetics and pathogen susceptibility data in the design of rational dosing regimens. Maglio D; Nicolau DP Methods Find Exp Clin Pharmacol; 2004 Dec; 26(10):781-8. PubMed ID: 15672121 [TBL] [Abstract][Full Text] [Related]
15. The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations. Preston SL Ann Pharmacother; 2004 Sep; 38(9 Suppl):S14-8. PubMed ID: 15226489 [TBL] [Abstract][Full Text] [Related]
16. Applying pharmacokinetic/pharmacodynamic principles for optimizing antimicrobial therapy during continuous renal replacement therapy. Honore PM; Jacobs R; De Waele E; Spapen HD Anaesthesiol Intensive Ther; 2017; 49(5):412-418. PubMed ID: 29171000 [TBL] [Abstract][Full Text] [Related]
17. Can PK/PD be used in everyday clinical practice. Scaglione F Int J Antimicrob Agents; 2002 Apr; 19(4):349-53. PubMed ID: 11978506 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Varghese JM; Roberts JA; Lipman J Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984 [TBL] [Abstract][Full Text] [Related]
19. Animal model pharmacokinetics and pharmacodynamics: a critical review. Andes D; Craig WA Int J Antimicrob Agents; 2002 Apr; 19(4):261-8. PubMed ID: 11978497 [TBL] [Abstract][Full Text] [Related]
20. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents. Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]